SCHEMBL6169040

SCHEMBL6169040

Cc1c[nH]cn1.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2513 0.97
Ethane SCHEMBL15300165 0.94
Iodide SCHEMBL13274496 0.94
SCHEMBL16694372 0.94
Piperazine SCHEMBL3259121 0.85
SCHEMBL18917184 0.78 ALDH1A1 (0.64)
SCHEMBL8563693 0.76 NPC1 (0.30)
SCHEMBL2011890 0.75
1-Methylimidazole SCHEMBL11120817 0.75 QPCT (0.56)
SCHEMBL30950402 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1285588-C Farnesyl protein transferase inhibitors SCHERING CORP (US) 2006-11-22 CN disclosed
EP-1140904-B1 FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORP (US) 2005-04-20 EP disclosed
US-6800636-B2 FOR THERAPY OF CANCER SCHERING CORPORATION 2004-10-05 US disclosed
US-20030040520-A1 Farnesyl protein transferase inhibitors GUZI TIMOTHY (US) 2003-02-27 US disclosed
CN-1352642-A Farnesyl protein transferase inhibitors SCHERING CORP (US) 2002-06-05 CN disclosed
US-6362188-B1 ANTICANCER AGENTS SCHERING CORPORATION 2002-03-26 US disclosed
EP-1140904-A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORPORATION (US) 2001-10-10 EP disclosed
WO-2000037458-A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORPORATION (US) 2000-06-29 WO disclosed